Patents by Inventor Bilal Abou Aleiwi

Bilal Abou Aleiwi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER
    Publication number: 20220089540
    Abstract: The disclosure relates to rexinoids, including compounds of the Formula (I) and (II) or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof. These rexinoids are useful for increasing PD-L1 in vivo, for treatment of cancer, and for inhibiting the onset of cancer.
    Type: Application
    Filed: January 17, 2020
    Publication date: March 24, 2022
    Inventors: Karen Liby, Ana Sofia Mendes Leal, Edmund Ellsworth, Bilal Abou Aleiwi
  • Inhibitors of paxillin function and related compositions and methods
    Patent number: 9834525
    Abstract: This disclosure relates to small molecule inhibitors of paxillin and paxillin binding, and related compositions and methods of treatment.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: December 5, 2017
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Charles Ryan Yates, Duane D. Miller, Frank Park, Jordan J. Toutounchian, Vanessa Morales-Tirado, Shivaputra Patil, Jayaprakash Pagadala, Bilal Abou Aleiwi